CVRx, Inc. (CVRX)

Market Cap	321.02M
Revenue (ttm)	51.29M
Net Income (ttm)	-59.97M
Shares Out	26.04M
EPS (ttm)	-2.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	148,314
Open	12.62
Previous Close	12.60
Day's Range	12.33 - 12.93
52-Week Range	6.40 - 19.24
Beta	1.29
Analysts	Strong Buy
Price Target	17.83 (+44.61%)
Earnings Date	Apr 29, 2025

About CVRX

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minn...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 30, 2021
• Employees: 206
• Stock Exchange: NASDAQ
• Ticker Symbol: CVRX
• Website: https://www.cvrx.com

Financial Performance

In 2024, CVRx, Inc.'s revenue was $51.29 million, an increase of 30.53% compared to the previous year's $39.30 million. Losses were -$59.97 million, 45.5% more than in 2023.

Analyst Forecast

According to 7 analysts, the average rating for CVRX stock is "Strong Buy." The 12-month stock price forecast is $17.83, which is an increase of 44.61% from the latest price.

Price Target

$17.83

(44.61% upside)

Analyst Consensus: Strong Buy